NCT06140563Completed
Variability in Micro-CT Imaging Results to Quantify Dialyzer Clotting
Prospective Study of Micro-CT Imaging to Quantify Dialyzer Clotting in Patients With End Stage Kidney Disease Undergoing Hemodialysis
Source: ClinicalTrials.gov · Last updated 22 Feb 2024
Brief summary (registry, in English)
Different cross-over studies have been performed investigating dialyzer fiber patency in different dialysis setups. Herewith, post dialysis micro computed tomography (CT) images of the dialyzer were compared. For the best interpretation of such results, one should have an idea about the intrapatient variability. There is also no clue about the impact of long distance transportation and long cold storage on the reproducibility of the micro CT images. Another bottle neck is that, up till now, no biochemical parameter or test has been found associated with the outcome of dialyzer fiber patency post dialysis. The present study therefore aims at determining the intrapatient variability and the impact on the micro CT results of long distance transportation and long cold storage of the dialyzers. Also, whole blood thrombin generation tests are performed to look for associations with the micro CT results.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 13 Nov 2023
- Start date
- 8 Jan 2024
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- University Hospital, Ghent
- Diseases
- Chronic kidney disease
- NCT number
- NCT06140563
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 8 Jan 2024 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- known coagulation disorder
- malignancy
Other
- ultrafiltration rate higher than 4 litre per session
- use of antiplatelets or anticoagulants (apart from acetylsalicylic acid)
- active inflammation
Who the study is looking for
- stable chronic hemodialysis patient
- well functioning vascular access
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent university hospital Coordinator of this site? Confirm its status | Ghent | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.